Clinical Trial Update: A Single Ascending Dose Study of Soluble Ferric Pyrophosphate Administered Intravenously in Healthy Volunteers. [Phase 1]

View source ↗

Summary

A Phase 1 single ascending-dose study evaluating the safety, tolerability, and pharmacokinetics of intravenous soluble ferric pyrophosphate in healthy volunteer…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• End-stage Renal Disease

Drugs mentioned

• Triferic (ferric pyrophosphate)

Snippet

Sponsor: Rockwell Medical Technologies, Inc. | Conditions: Kidney Failure, Chronic Therapy; Hemodialysis | Phase 1 | Status: COMPLETED | Results posted: 2014-12-19